PN
Perry Nisen
OtherActiveExecutive Partner at Sofinnova Investments
67
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Perry Nisen.
Investment Thesis & Strategy
Perry Nisen, as an Executive Partner at Sofinnova Investments, invests in various stages of biotech, consumer health, healthcare, health & hospital services, and health IT companies. He likely seeks innovative companies with strong growth potential within the healthcare and life sciences sectors.
Portfolio Companies
Selected investments from their portfolio of 67 companies
A
Atsena Therapeutics
Other · , 0
R
Rainier Therapeutics
Other · , 0
G
Galera Therapeutics
Other · , 0
N
NextCure
Other · , 0
C
ConteXtream
Other · , 0
C
Chiasma
Other · , 0
A
Aclaris Therapeutics
Other · , 0
V
Vera Therapeutics
Other · , 0
C
Checkmate Pharmaceuticals
Other · , 0
F
First Aid Shot Therapy
Other · , 0
A
Apellis Pharmaceuticals
Other · , 0
M
McPhy
Other · , 0
Frequently Asked Questions
Perry Nisen focuses on Seed stage investments.